LMNL logo

Liminal BioSciences (LMNL) Net Income

Annual Net Income

$384.30 K
-$9.89 M-96.26%

December 31, 2022

Summary

Performance

1-Year Change

-96.26%

3-Year Change

+100.25%

5-Year Change

+100.45%

15-Year Change

+100.45%

LMNL Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$10.27 M
LMNL annual net profit is currently -96.26% below its historical high of $10.27 million

3-Year Low

$384.30 K
LMNL annual net profit is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
LMNL previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
LMNL next annual earnings announcement has not yet been scheduled

OtherLMNLprofitabilitymetrics:

Annual Net Margin

-
LMNL annual net profit margin value is unknown

Annual Revenue

$308.20 K
LMNL annual revenue is $308.20 thousand

Annual Gross Profit

-
LMNL annual gross profit value is unknown

Annual EPS

$0.12
LMNL annual earnings per share is $0.12

Quarterly Net Income

-$6.80 M
-$1.30 M-23.71%

June 30, 2023

Summary

Performance

3-Month Change

-23.71%

1-Year Change

-46.26%

3-Year Change

+66.07%

5-Year Change

+72.83%

LMNL Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$59.10 M
LMNL quarterly net profit is currently -111.50% below its historical high of $59.10 million

3-Year Low

-$8.45 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
LMNL previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
LMNL next earnings announcement has not yet been scheduled

OtherLMNLprofitabilitymetrics:

Quarterly Net Margin

-8161.63%
LMNL quarterly net profit margin is -8161.63%

Quarterly Revenue

$83.30 K
LMNL quarterly revenue is $83.30 thousand

Quarterly Gross Profit

-
LMNL quarterly gross profit value is unknown

Quarterly EPS

-$2.19
LMNL quarterly earnings per share is -$2.19

TTM Net Income

$903.00 K
-$2.15 M-70.42%

June 30, 2023

Summary

Performance

3-Month Change

-70.42%

1-Year Change

-97.66%

3-Year Change

+101.23%

5-Year Change

+100.59%

LMNL TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$38.67 M
LMNL TTM net profit is currently -97.66% below its historical high of $38.67 million

3-Year Low

-$3.64 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
LMNL previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
LMNL next earnings announcement has not yet been scheduled

OtherLMNLprofitabilitymetrics:

Annual Net Margin

-
LMNL annual net profit margin value is unknown

TTM Revenue

$363.50 K
LMNL TTM revenue is $363.50 thousand

TTM Gross Profit

-
LMNL TTM gross profit value is unknown

TTM EPS

$0.27
LMNL TTM earnings per share is $0.27

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

$384.30 K
LMNL annual net profit is $384.30 thousand

Annual Revenue

$308.20 K
LMNL annual revenue is $308.20 thousand

Annual Cost Of Goods Sold

-
LMNL annual cost of goods sold value is unknown

Annual Operating Expenses

$25.49 M
LMNL annual total operating expenses is $25.49 million

Annual Interest Expense

$828.60 K
LMNL annual interest expense is $828.60 thousand

Annual Income Tax

-$403.50 K
LMNL annual income tax is -$403.50 thousand

LMNL Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-96.3%-46.3%-97.7%
3 y3 years+100.3%+66.1%+101.2%
5 y5 years+100.5%+72.8%+100.6%

LMNL Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-96.3%at low-140.5%+24.3%-97.7%-503.5%
5 y5-year-96.3%<-9999.0%-111.5%+348.5%-97.7%<-9999.0%
alltimeall time-96.3%<-9999.0%-111.5%+1370.2%-97.7%<-9999.0%

Liminal BioSciences Net Income History

DateAnnualQuarterlyTTM
Jun 2023
-
-$6.80 M(+23.7%)
$903.00 K(-70.4%)
Mar 2023
-
-$5.49 M(+52.9%)
$3.05 M(+2998.8%)
Dec 2022
$384.30 K(-96.3%)
-$3.59 M(-121.4%)
$98.50 K(-102.7%)
Sep 2022
-
$16.78 M(-461.2%)
-$3.64 M(-109.4%)
Jun 2022
-
-$4.65 M(-45.0%)
$38.67 M(+124.5%)
Mar 2022
-
-$8.45 M(+15.2%)
$17.23 M(+77.9%)
Dec 2021
$10.27 M(-111.7%)
-$7.33 M(-112.4%)
$9.68 M(-171.9%)
Sep 2021
-
$59.10 M(-326.5%)
-$13.46 M(-85.0%)
Jun 2021
-
-$26.09 M(+63.2%)
-$89.89 M(+7.2%)
Mar 2021
-
-$15.99 M(-47.5%)
-$83.83 M(-5.0%)
Dec 2020
-$88.01 M(-43.2%)
-$30.48 M(+75.9%)
-$88.23 M(+28.6%)
Sep 2020
-
-$17.33 M(-13.5%)
-$68.62 M(-6.9%)
Jun 2020
-
-$20.03 M(-1.8%)
-$73.70 M(-52.0%)
Mar 2020
-
-$20.39 M(+87.6%)
-$153.58 M(-0.5%)
Dec 2019
-$154.99 M(+2.8%)
-$10.87 M(-51.5%)
-$154.34 M(-30.3%)
Sep 2019
-
-$22.41 M(-77.6%)
-$221.32 M(+0.3%)
Jun 2019
-
-$99.91 M(+372.3%)
-$220.70 M(+51.4%)
Mar 2019
-
-$21.15 M(-72.8%)
-$145.80 M(-2.6%)
Dec 2018
-$150.76 M(+78.1%)
-$77.86 M(+257.5%)
-$149.72 M(+46.8%)
Sep 2018
-
-$21.78 M(-12.9%)
-$101.96 M(+10.1%)
Jun 2018
-
-$25.01 M(-0.3%)
-$92.58 M(+3.4%)
Mar 2018
-
-$25.08 M(-16.7%)
-$89.51 M(+6.1%)
Dec 2017
-$84.67 M(+11.2%)
-$30.10 M(+142.7%)
-$84.37 M(+2.6%)
Sep 2017
-
-$12.40 M(-43.5%)
-$82.23 M(-8.1%)
Jun 2017
-
-$21.94 M(+10.1%)
-$89.43 M(+5.4%)
Mar 2017
-
-$19.93 M(-28.7%)
-$84.84 M(+11.3%)
Dec 2016
-$76.12 M(+90.6%)
-$27.95 M(+42.6%)
-$76.25 M(+35.5%)
Sep 2016
-
-$19.60 M(+13.0%)
-$56.29 M(+28.7%)
Jun 2016
-
-$17.34 M(+52.8%)
-$43.74 M(+20.2%)
Mar 2016
-
-$11.35 M(+42.0%)
-$36.38 M(-9.5%)
Dec 2015
-$39.93 M(-842.2%)
-$7.99 M(+13.3%)
-$40.20 M(+66.8%)
Sep 2015
-
-$7.05 M(-29.4%)
-$24.10 M(-30.7%)
Jun 2015
-
-$9.99 M(-34.2%)
-$34.75 M(+1140.2%)
Mar 2015
-
-$15.17 M(-287.0%)
-$2.80 M(-154.5%)
Dec 2014
$5.38 M(-133.6%)
$8.11 M(-145.8%)
$5.14 M(-153.3%)
Sep 2014
-
-$17.71 M(-180.6%)
-$9.65 M(-421.6%)
Jun 2014
-
$21.96 M(-404.0%)
$3.00 M(-114.0%)
Mar 2014
-
-$7.22 M(+8.2%)
-$21.36 M(+34.4%)
Dec 2013
-$16.01 M(-6940.2%)
-$6.68 M(+32.0%)
-$15.89 M(+98.1%)
Sep 2013
-
-$5.06 M(+111.3%)
-$8.02 M(+1599.2%)
Jun 2013
-
-$2.39 M(+36.2%)
-$472.10 K(-117.4%)
Mar 2013
-
-$1.76 M(-247.6%)
$2.71 M(+898.8%)
Dec 2012
$234.10 K(-109.1%)
$1.19 M(-52.1%)
$271.60 K(-89.3%)
Sep 2012
-
$2.49 M(+215.0%)
$2.55 M(-231.5%)
Jun 2012
-
$790.20 K(-118.8%)
-$1.94 M(-56.4%)
Mar 2012
-
-$4.20 M(-221.2%)
-$4.44 M(+60.3%)
Dec 2011
-$2.58 M(-74.4%)
$3.46 M(-273.9%)
-$2.77 M(-73.3%)
Sep 2011
-
-$1.99 M(+16.5%)
-$10.35 M(-5.0%)
Jun 2011
-
-$1.71 M(-32.3%)
-$10.89 M(+10.4%)
Mar 2011
-
-$2.53 M(-38.6%)
-$9.87 M(-2.4%)
Dec 2010
-$10.08 M
-$4.12 M(+62.5%)
-$10.11 M(+22.9%)
Sep 2010
-
-$2.53 M(+269.4%)
-$8.23 M(+48.4%)
DateAnnualQuarterlyTTM
Jun 2010
-
-$686.10 K(-75.3%)
-$5.55 M(-40.0%)
Mar 2010
-
-$2.77 M(+24.1%)
-$9.24 M(+14.0%)
Dec 2009
-$8.21 M(-56.8%)
-$2.23 M(-1603.4%)
-$8.10 M(-20.0%)
Sep 2009
-
$148.60 K(-103.4%)
-$10.13 M(-26.4%)
Jun 2009
-
-$4.38 M(+167.4%)
-$13.77 M(-7.7%)
Mar 2009
-
-$1.64 M(-61.6%)
-$14.92 M(-21.6%)
Dec 2008
-$19.00 M(-9.1%)
-$4.26 M(+22.0%)
-$19.04 M(-8.4%)
Sep 2008
-
-$3.49 M(-36.8%)
-$20.78 M(-13.3%)
Jun 2008
-
-$5.53 M(-3.9%)
-$23.96 M(+5.0%)
Mar 2008
-
-$5.75 M(-4.2%)
-$22.82 M(+8.4%)
Dec 2007
-$20.90 M(-22.2%)
-$6.00 M(-10.1%)
-$21.05 M(-11.5%)
Sep 2007
-
-$6.68 M(+52.3%)
-$23.78 M(+1.7%)
Jun 2007
-
-$4.39 M(+10.2%)
-$23.38 M(-7.7%)
Mar 2007
-
-$3.98 M(-54.4%)
-$25.34 M(-5.6%)
Dec 2006
-$26.85 M(+41.8%)
-$8.73 M(+38.9%)
-$26.85 M(+8.3%)
Sep 2006
-
-$6.28 M(-1.0%)
-$24.79 M(+6.9%)
Jun 2006
-
-$6.34 M(+15.4%)
-$23.19 M(+1.6%)
Mar 2006
-
-$5.50 M(-17.6%)
-$22.84 M(+20.3%)
Dec 2005
-$18.93 M(+43.4%)
-$6.67 M(+42.6%)
-$18.99 M(+9.8%)
Sep 2005
-
-$4.68 M(-21.9%)
-$17.30 M(+7.2%)
Jun 2005
-
-$5.99 M(+264.4%)
-$16.14 M(+44.7%)
Mar 2005
-
-$1.64 M(-67.0%)
-$11.15 M(-16.7%)
Dec 2004
-$13.21 M(-9.1%)
-$4.98 M(+41.7%)
-$13.39 M(+3.6%)
Sep 2004
-
-$3.52 M(+250.7%)
-$12.92 M(+0.4%)
Jun 2004
-
-$1.00 M(-74.2%)
-$12.87 M(-18.0%)
Mar 2004
-
-$3.88 M(-14.1%)
-$15.70 M(+7.5%)
Dec 2003
-$14.52 M(+61.5%)
-$4.52 M(+30.4%)
-$14.60 M(+14.6%)
Sep 2003
-
-$3.47 M(-9.6%)
-$12.74 M(+12.5%)
Jun 2003
-
-$3.83 M(+37.9%)
-$11.32 M(+14.9%)
Mar 2003
-
-$2.78 M(+4.7%)
-$9.85 M(+9.5%)
Dec 2002
-$8.99 M(+65.4%)
-$2.66 M(+29.7%)
-$9.00 M(+11.6%)
Sep 2002
-
-$2.05 M(-13.3%)
-$8.06 M(+11.7%)
Jun 2002
-
-$2.36 M(+22.9%)
-$7.22 M(+15.4%)
Mar 2002
-
-$1.92 M(+11.5%)
-$6.25 M(+15.3%)
Dec 2001
-$5.44 M(+56.2%)
-$1.73 M(+43.5%)
-$5.42 M(+20.1%)
Sep 2001
-
-$1.20 M(-14.1%)
-$4.51 M(+3.5%)
Jun 2001
-
-$1.40 M(+27.9%)
-$4.36 M(+13.6%)
Mar 2001
-
-$1.09 M(+34.1%)
-$3.84 M(+11.9%)
Dec 2000
-$3.48 M(-81.7%)
-$816.50 K(-22.1%)
-$3.43 M(+60.4%)
Sep 2000
-
-$1.05 M(+19.4%)
-$2.14 M(-84.3%)
Jun 2000
-
-$878.10 K(+27.6%)
-$13.60 M(-17.7%)
Mar 2000
-
-$688.00 K(-244.7%)
-$16.53 M(-12.8%)
Dec 1999
-$19.05 M(+334.1%)
$475.60 K(-103.8%)
-$18.95 M(-10.2%)
Sep 1999
-
-$12.51 M(+229.0%)
-$21.11 M(+123.2%)
Jun 1999
-
-$3.80 M(+22.4%)
-$9.46 M(+44.3%)
Mar 1999
-
-$3.11 M(+84.3%)
-$6.55 M(+50.5%)
Dec 1998
-$4.39 M(+87.8%)
-$1.69 M(+96.3%)
-$4.35 M(+21.3%)
Sep 1998
-
-$859.10 K(-4.4%)
-$3.59 M(+31.5%)
Jun 1998
-
-$898.90 K(-1.2%)
-$2.73 M(+49.1%)
Mar 1998
-
-$909.60 K(-1.5%)
-$1.83 M(+98.5%)
Dec 1997
-
-$923.00 K
-$923.00 K
Sep 1997
-$2.34 M
-
-

FAQ

  • What is Liminal BioSciences annual net profit?
  • What is the all time high annual net income for Liminal BioSciences?
  • What is Liminal BioSciences annual net income year-on-year change?
  • What is Liminal BioSciences quarterly net profit?
  • What is the all time high quarterly net income for Liminal BioSciences?
  • What is Liminal BioSciences quarterly net income year-on-year change?
  • What is Liminal BioSciences TTM net profit?
  • What is the all time high TTM net income for Liminal BioSciences?
  • What is Liminal BioSciences TTM net income year-on-year change?

What is Liminal BioSciences annual net profit?

The current annual net income of LMNL is $384.30 K

What is the all time high annual net income for Liminal BioSciences?

Liminal BioSciences all-time high annual net profit is $10.27 M

What is Liminal BioSciences annual net income year-on-year change?

Over the past year, LMNL annual net profit has changed by -$9.89 M (-96.26%)

What is Liminal BioSciences quarterly net profit?

The current quarterly net income of LMNL is -$6.80 M

What is the all time high quarterly net income for Liminal BioSciences?

Liminal BioSciences all-time high quarterly net profit is $59.10 M

What is Liminal BioSciences quarterly net income year-on-year change?

Over the past year, LMNL quarterly net profit has changed by -$2.15 M (-46.26%)

What is Liminal BioSciences TTM net profit?

The current TTM net income of LMNL is $903.00 K

What is the all time high TTM net income for Liminal BioSciences?

Liminal BioSciences all-time high TTM net profit is $38.67 M

What is Liminal BioSciences TTM net income year-on-year change?

Over the past year, LMNL TTM net profit has changed by -$37.77 M (-97.66%)